$13.30

+1.28 (+10.65%)

Weekly Expected Move ±17.9%

$8 $10 $12 $14 $16

NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 66 · $195.9M mcap · 11M float · 1.80% daily turnover · Short 66% of daily vol

Credit Risk of going bust: higher than 95% of companies Debt: 17.7% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.87 (down 93%), Korro Bio, Inc. would be worth roughly what it owes.
Total debt $42.2M against a stock market value of $195.9M.
Distance to default 0.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.1M (short-term plus half of long-term), stock volatility 179.9%; Altman Z'' -5.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

37.8 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: -196.6% · 5Y Avg: -436.7%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KRRO has No discernible competitive edge (37.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -196.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$15

Low

$15

Avg Target

$15

High

Based on 1 analyst since Aug 6, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 10Hold: 2Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$15.00

Analysts1

Consensus Change History

Date	Field	From	To
2026-01-29	consensus	Hold	Buy

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-06	Jefferies	—	Initiated	$15	—	+50.5%	$9.97
2026-05-19	H.C. Wainwright	Mitchell Kapoor	$20	$15	-5	+50.5%	$9.97
2026-03-13	Cantor Fitzgerald	Steve Seehouse	$21	$22	+1	+91.3%	$11.50
2026-03-13	Raymond James	Ryan Deschner	$18	$23	+5	+100.0%	$11.50
2026-02-18	Raymond James	—	Initiated	$18	—	+60.2%	$11.23
2026-01-29	H.C. Wainwright	—	$115	$20	-95	+71.1%	$11.69
2026-01-29	Chardan Capital	—	$25	$15	-10	+28.3%	$11.69
2026-01-28	Piper Sandler	Yasmeen Rahimi	Initiated	$30	—	+156.6%	$11.69
2026-01-28	William Blair	Myles Minter	Initiated	$10	—	-10.5%	$11.17
2026-01-28	Oppenheimer	—	Initiated	$22	—	+104.8%	$10.74
2026-01-27	Cantor Fitzgerald	Steve Seedhouse	Initiated	$21	—	+95.5%	$10.74
2025-04-16	Chardan Capital	Keay Nakae	Initiated	$25	—	+85.7%	$13.46
2024-10-21	RBC Capital	Luca Issi	$90	$105	+15	+36.5%	$76.94
2024-05-15	BMO Capital	Kostas Biliouris	Initiated	$120	—	+139.8%	$50.05
2024-03-28	H.C. Wainwright	—	Initiated	$115	—	+29.9%	$88.53
2024-03-27	RBC Capital	—	Initiated	$90	—	+0.2%	$89.83

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KRRO receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).

Rating Change History

Date	From	To
2026-08-06	C	C-
2026-05-07	C-	C
2026-03-13	C	C-
2026-01-12	C+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+

Profitability

—

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

-2.00

Distress Zone

Piotroski F-Score

2/9

✗ ✗ ✗ ✓ ✗ ✓ ✗ ✗ ✗

Beneish M-Score

—

Ohlson O-Score

-3.80

Bankruptcy prob: 2.2%

Low Risk

Credit Rating

Score: 42.6/100

Trend: Stable

Earnings Quality

—

OCF/NI: 0.64x

Accruals: -22.5%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KRRO scores -2.00, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KRRO scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KRRO's implied 2.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KRRO receives an estimated rating of BB (score: 42.6/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-1.33x

PEG

0.09x

P/S

82.22x

P/B

2.27x

P/FCF

-3.40x

P/OCF

—

EV/EBITDA

-2.22x

EV/Revenue

66.91x

EV/EBIT

-2.14x

EV/FCF

-2.33x

Earnings Yield

-45.93%

FCF Yield

-29.40%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. KRRO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.008

NI / EBT

Interest Burden

1.420

EBT / EBIT

EBIT Margin

-31.272

EBIT / Rev

Asset Turnover

0.014

Rev / Assets

Equity Multiplier

1.575

Assets / Equity

ROE

-97.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KRRO's ROE of -97.7% is driven by Asset Turnover (0.014), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1776 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$13.30

Median 1Y

$2.74

5th Pctile

$0.23

95th Pctile

$33.02

Ann. Volatility

143.1%

Analyst Target

$15.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

-44.2% YoY

Revenue / Employee

$110,207

Rev: $6,392,000

Profit / Employee

$-2,021,724

NI: $-117,260,000

SGA / Employee

$485,500

Avg labor cost proxy

R&D / Employee

$1,130,603

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-42.4%	-52.4%	-60.5%	-63.4%	-67.6%	-4.6%	-68.3%	-87.4%	-1.1%	-2.3%	-66.9%	-62.7%	-74.5%	-50.6%	-60.2%	-58.3%	-63.5%	-1.1%	-87.8%	-97.7%	-97.69%
ROA	-33.6%	-37.6%	-43.2%	-44.9%	-45.8%	-56.6%	-52.5%	-57.3%	-63.1%	-55.0%	-54.4%	-47.5%	-51.7%	-37.3%	-43.7%	-42.5%	-43.7%	-69.0%	-58.8%	-62.0%	-62.03%
ROIC	-1.3%	-1.5%	-1.7%	-2.2%	-2.3%	-4.9%	-4.0%	-1.4%	-1.5%	-1.8%	-1.4%	-91.5%	-89.6%	-91.8%	-1.1%	-1.2%	-1.5%	-3.5%	-1.3%	-2.0%	-1.97%
ROCE	-38.0%	-48.2%	-56.9%	-62.2%	-66.4%	-1.1%	-75.8%	-72.7%	-84.3%	-40.9%	-45.2%	-38.3%	-41.6%	-43.5%	-50.4%	-60.4%	-63.5%	-84.8%	-48.3%	-49.4%	-49.39%
Gross Margin	—	—	—	—	—	—	—	—	—	—	—	—	—	1.0%	1.0%	1.0%	1.0%	49.8%	—	—	—
Operating Margin	—	—	—	—	—	—	—	—	—	—	—	—	—	-10.1%	-9.8%	-18.6%	-17.6%	-12.3%	—	—	—
Net Margin	—	—	—	—	—	—	—	—	—	—	—	—	—	-9.3%	-9.2%	-17.7%	-16.6%	-38.7%	—	—	—
EBITDA Margin	—	—	—	—	—	—	—	—	—	—	—	—	—	-9.6%	-9.3%	-17.8%	-15.5%	-11.8%	—	—	—
FCF Margin	-3.3%	-5.6%	-7.5%	—	—	—	—	—	—	—	—	—	—	-34.3%	-15.6%	-11.8%	-9.5%	-12.4%	-18.4%	-28.7%	-28.66%
OCF Margin	-3.0%	-5.4%	-7.2%	—	—	—	—	—	—	—	—	—	—	-26.5%	-13.0%	-10.7%	-9.3%	-12.3%	-18.3%	-28.5%	-28.53%
ROE 3Y Avg	snapshot only																				-75.25%
ROE 5Y Avg	snapshot only																				-82.55%
ROA 3Y Avg	snapshot only																				-50.02%
ROIC 3Y Avg	snapshot only																				-1.37%
ROIC Economic	snapshot only																				-41.11%
Cash ROA	snapshot only																				-41.57%
Cash ROIC	snapshot only																				-2.23%
CROIC	snapshot only																				-2.25%
NOPAT Margin	snapshot only																				-25.09%
Pretax Margin	snapshot only																				-44.42%
R&D / Revenue	snapshot only																				21.55%
SGA / Revenue	snapshot only																				11.21%
SBC / Revenue	snapshot only																				3.15%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-3.31	-2.10	-0.84	-0.63	-6.04	-14.18	-1.98	-1.30	-1.45	-4.73	-8.90	-3.57	-3.54	-4.06	-1.87	-1.28	-5.09	-0.64	-1.16	-2.18	-1.329
P/S Ratio	10.13	12.62	7.84	—	—	—	—	—	—	—	—	—	—	149.54	33.89	18.67	61.02	11.77	34.17	97.49	82.221
P/B Ratio	1.65	1.36	0.65	0.55	5.71	-10.50	1.51	1.30	1.89	2.26	4.77	1.54	1.73	2.12	1.18	1.02	4.54	1.46	1.10	2.25	2.270
P/FCF	-3.03	-2.25	-1.05	-0.83	-7.86	-17.98	-2.23	-1.41	-1.54	-3.84	-6.79	-2.83	-2.66	-4.36	-2.18	-1.59	-6.40	-0.95	-1.86	-3.40	-3.402
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBITDA	-2.02	-1.15	-0.02	0.18	-5.68	-16.84	-0.92	-0.94	-1.32	-3.18	-7.65	-2.12	-2.33	-2.92	-1.02	-0.70	-4.53	-0.53	-0.77	-2.22	-2.216
EV/Revenue	5.88	6.57	0.17	—	—	—	—	—	—	—	—	—	—	113.73	19.42	10.44	54.40	6.82	15.67	66.91	66.914
EV/EBIT	-1.94	-1.10	-0.02	0.17	-5.36	-15.83	-0.87	-0.88	-1.25	-3.04	-7.33	-2.04	-2.25	-2.81	-0.98	-0.67	-4.30	-0.51	-0.74	-2.14	-2.140
EV/FCF	-1.76	-1.17	-0.02	0.22	-6.93	-19.91	-0.98	-0.95	-1.33	-2.51	-5.82	-1.72	-1.85	-3.31	-1.25	-0.89	-5.71	-0.55	-0.85	-2.33	-2.335
Earnings Yield	-30.2%	-47.7%	-1.2%	-1.6%	-16.6%	-7.0%	-50.6%	-77.0%	-69.1%	-21.1%	-11.2%	-28.0%	-28.2%	-24.6%	-53.5%	-77.9%	-19.7%	-1.6%	-86.4%	-45.9%	-45.93%
FCF Yield	-33.0%	-44.5%	-95.3%	-1.2%	-12.7%	-5.6%	-44.9%	-71.0%	-64.8%	-26.0%	-14.7%	-35.4%	-37.5%	-23.0%	-45.9%	-63.0%	-15.6%	-1.1%	-53.8%	-29.4%	-29.40%
PEG Ratio	snapshot only																				0.087
Price/Tangible Book	snapshot only																				2.250
EV/Gross Profit	snapshot only																				91.972
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	14.30	11.79	9.85	6.77	5.05	6.56	9.15	7.65	5.15	8.87	13.18	13.28	11.23	8.79	9.41	5.98	6.71	6.90	8.13	9.55	9.553
Quick Ratio	14.30	11.79	9.85	6.77	5.05	6.56	9.15	7.65	5.15	8.87	13.18	13.28	11.23	8.79	9.41	5.98	6.71	6.90	8.13	9.55	9.553
Debt/Equity	0.31	0.35	0.40	0.47	0.54	-1.69	0.03	0.39	0.56	0.20	0.24	0.19	0.23	0.28	0.33	0.39	0.45	0.85	0.36	0.41	0.409
Net Debt/Equity	-0.69	-0.65	-0.64	-0.69	-0.67	—	-0.85	-0.42	-0.27	-0.78	-0.68	-0.60	-0.53	-0.51	-0.50	-0.45	-0.49	-0.62	-0.59	-0.71	-0.705
Debt/Assets	0.23	0.25	0.27	0.30	0.33	2.26	0.02	0.27	0.33	0.15	0.18	0.15	0.17	0.20	0.22	0.25	0.28	0.38	0.23	0.26	0.258
Debt/EBITDA	-0.66	-0.57	-0.55	-0.57	-0.61	-2.44	-0.04	-0.42	-0.45	-0.42	-0.44	-0.44	-0.45	-0.51	-0.49	-0.47	-0.51	-0.53	-0.55	-0.59	-0.587
Net Debt/EBITDA	1.46	1.06	0.88	0.84	0.76	-1.63	1.18	0.45	0.22	1.68	1.27	1.36	1.03	0.92	0.76	0.55	0.55	0.39	0.91	1.01	1.013
Interest Coverage	-125.17	-109.83	-159.24	-227.06	-173.00	-126.46	-80.47	-85.65	-122.08	-290.89	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.37	1.42	1.46	1.56	1.66	-0.74	1.10	1.48	1.71	1.30	1.31	1.26	1.36	1.41	1.46	1.57	1.63	2.21	1.53	1.58	1.583
Cash Ratio	snapshot only																				9.110
Cash to Debt	snapshot only																				2.725
FCF to Debt	snapshot only																				-1.617
Defensive Interval	snapshot only																				542.5 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.11	0.06	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.02	0.03	0.04	0.04	0.02	0.01	0.014
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	—	58.13	—	—	—	0.00	—	—	—	0.00	—	—	0.00	2.68	5.01	11.54	1.36	4.80	3.99	4.37	4.375
Payables Turnover	4.00	1.64	0.89	0.92	1.00	1.41	0.97	1.20	1.15	0.54	0.40	0.20	0.00	0.00	0.00	0.00	0.00	0.23	0.21	0.15	0.148
DSO	0	6	0	—	—	—	—	—	—	—	—	—	—	136	73	32	268	76	91	83	83.4 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	0	0	0	0.0 days
DPO	91	223	409	395	365	259	377	304	318	682	911	1807	—	—	—	—	—	1587	1725	2465	2465.0 days
Cash Conversion Cycle	-91	-216	-409	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1511	-1633	-2382	-2381.6 days
Fixed Asset Turnover	snapshot only																				0.158
Cash Velocity	snapshot only																				0.021
Capital Intensity	snapshot only																				68.617

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	-24.3%	-62.0%	-72.6%	-1.0%	-1.0%	-1.0%	-1.0%	—	—	—	—	—	—	—	—	—	—	1.8%	-20.3%	-62.1%	-62.08%
Net Income	-2.4%	-2.2%	-1.1%	-55.0%	-5.5%	13.4%	20.7%	10.7%	5.6%	-10.7%	-16.6%	-15.0%	-20.1%	-3.0%	-7.7%	-7.1%	-0.7%	-40.3%	-29.8%	-16.7%	-16.74%
EPS	-2.2%	-2.1%	-1.0%	-51.7%	86.1%	88.9%	89.9%	88.8%	13.7%	25.4%	20.5%	28.8%	26.2%	7.5%	7.9%	-2.5%	0.3%	-33.2%	-5.1%	37.8%	37.78%
FCF	-27.9%	-52.3%	-3.1%	17.7%	25.8%	26.8%	12.3%	-8.3%	-15.2%	-72.9%	-72.3%	-57.6%	-70.1%	22.0%	29.4%	31.4%	39.8%	-1.4%	5.9%	7.6%	7.57%
EBITDA	-2.4%	-2.2%	-1.1%	-55.7%	-4.1%	14.6%	20.8%	11.8%	5.2%	-15.5%	-23.9%	-26.3%	-34.3%	-11.9%	-13.0%	-7.3%	4.4%	7.3%	14.5%	23.5%	23.48%
Op. Income	-2.1%	-2.1%	-1.1%	-55.1%	-7.0%	10.9%	17.6%	6.0%	1.8%	-13.9%	-20.9%	-17.8%	-24.9%	-7.7%	-10.1%	-7.6%	1.3%	5.0%	13.3%	23.2%	23.22%
OCF Growth	snapshot only																				-1.01%
Asset Growth	snapshot only																				-9.41%
Equity Growth	snapshot only																				-10.32%
Debt Growth	snapshot only																				-5.42%
Shares Change	snapshot only																				87.62%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	-45.6%	-20.0%	—	—	—	—	—	—
Revenue 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	-13.6%	-16.6%	-21.1%	-25.3%	-29.6%	-35.5%	-41.7%	-41.67%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	-32.2%	-6.9%	—	—	—	—	—	—
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-28.7%	-28.72%
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	—	—	—	—	—	-30.9%	-22.6%	-18.9%	-25.8%	-5.7%	-6.4%	4.3%	6.4%	6.9%	7.0%	6.4%	5.9%	15.5%	22.4%	14.3%	14.34%
Assets 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	0.3%	-1.3%	-2.5%	-7.2%	-15.6%	-5.3%	-5.8%	-5.79%
Equity 3Y	—	—	—	—	—	—	-17.9%	-23.0%	-34.5%	-4.1%	-5.2%	6.1%	6.9%	7.0%	7.2%	6.3%	6.5%	—	9.5%	11.8%	11.77%
Book Value 3Y	—	—	—	—	—	—	-60.3%	-62.9%	-68.1%	-57.9%	-58.3%	-55.0%	-55.1%	-54.4%	-54.9%	-55.3%	-12.4%	—	-14.8%	-23.9%	-23.88%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	0.08	0.01	0.33	0.92	0.08	0.29	0.53	0.88	0.85	0.80	0.60	0.60	0.19	0.53	0.41	0.47	0.51	0.54	0.55	0.553
Earnings Stability	—	0.93	0.99	1.00	0.80	0.80	0.73	0.78	0.59	0.76	0.70	0.76	0.65	0.72	0.70	0.76	0.65	0.70	0.69	0.82	0.823
Margin Stability	—	0.00	0.00	—	—	0.00	0.00	—	—	—	—	—	—	0.01	0.07	—	—	0.13	0.12	0.44	0.443
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	0.00	0.00	0.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	—	0.50	0.50	0.50	0.98	0.95	0.92	0.96	0.98	0.96	0.93	0.94	0.92	0.99	0.97	0.97	1.00	0.84	0.88	0.93	0.933
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	—	-0.56	-0.63	-0.65	-0.64	—	-0.26	-0.41	-0.58	—	0.24	0.50	0.64	—	0.02	-0.08	0.00	-1.78	-0.37	-0.42	-0.421
Gross Margin Trend	—	0.52	0.64	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin Trend	—	-1.71	-4.81	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.99	0.90	0.77	0.74	0.76	0.71	0.78	0.77	0.78	1.06	1.09	1.03	1.05	0.72	0.72	0.74	0.77	0.67	0.62	0.64	0.637
FCF/OCF	1.10	1.04	1.04	1.02	1.02	1.12	1.14	1.19	1.20	1.16	1.20	1.22	1.26	1.30	1.20	1.10	1.03	1.01	1.01	1.00	1.005
FCF/Net Income	snapshot only																				0.640
CapEx/Revenue	30.3%	20.7%	25.3%	—	—	—	—	—	—	—	—	—	—	7.9%	2.6%	1.0%	25.6%	8.1%	10.9%	13.3%	13.31%
CapEx/Depreciation	snapshot only																				0.123
Accruals Ratio	-0.00	-0.04	-0.10	-0.12	-0.11	-0.17	-0.12	-0.13	-0.14	0.03	0.05	0.02	0.03	-0.10	-0.12	-0.11	-0.10	-0.23	-0.22	-0.23	-0.225
Sloan Accruals	snapshot only																				0.116
Cash Flow Adequacy	snapshot only																				-214.347

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-0.7%	-0.8%	-1.3%	-1.3%	-0.1%	-0.0%	-0.1%	-0.1%	-0.0%	-42.6%	-22.7%	-76.0%	-74.6%	-20.4%	-42.5%	-1.6%	-0.3%	-0.9%	-67.6%	-37.0%	-36.95%
Total Shareholder Return	-0.7%	-0.8%	-1.3%	-1.3%	-0.1%	-0.0%	-0.1%	-0.1%	-0.0%	-42.6%	-22.7%	-76.0%	-74.6%	-20.4%	-42.5%	-1.6%	-0.3%	-0.9%	-67.6%	-37.0%	-36.95%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.01	1.01	1.01	1.008
Interest Burden (EBT/EBIT)	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.00	0.98	0.96	0.94	0.92	0.91	0.91	0.93	0.95	1.35	1.38	1.42	1.420
EBIT Margin	-3.03	-5.96	-9.23	—	—	—	—	—	—	—	—	—	—	-40.47	-19.80	-15.69	-12.66	-13.48	-21.23	-31.27	-31.272
Asset Turnover	0.11	0.06	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.02	0.03	0.04	0.04	0.02	0.01	0.014
Equity Multiplier	1.26	1.39	1.40	1.41	1.48	8.15	1.30	1.53	1.68	4.17	1.23	1.32	1.44	1.36	1.38	1.37	1.45	1.60	1.49	1.58	1.575

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-106.56	$-122.39	$-125.96	$-118.77	$-14.82	$-13.57	$-12.73	$-13.33	$-12.78	$-10.13	$-10.12	$-9.49	$-9.44	$-9.37	$-9.31	$-9.73	$-9.41	$-12.48	$-9.79	$-6.05	$-6.05
Book Value/Share	$213.53	$189.07	$161.83	$137.03	$15.68	$-18.33	$16.67	$13.28	$9.80	$21.20	$18.87	$22.04	$19.31	$17.98	$14.81	$12.26	$10.54	$5.47	$10.31	$5.86	$5.86
Tangible Book/Share	$213.53	$189.07	$161.83	$137.03	$15.68	$-18.33	$16.67	$13.28	$9.80	$21.20	$18.87	$22.04	$19.31	$17.98	$14.81	$12.26	$10.54	$5.47	$10.31	$5.86	$5.86
Revenue/Share	$34.86	$20.33	$13.53	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.25	$0.51	$0.67	$0.78	$0.68	$0.33	$0.14	$0.14
FCF/Share	$-116.51	$-114.14	$-100.99	$-90.21	$-11.39	$-10.70	$-11.29	$-12.28	$-11.99	$-12.48	$-13.26	$-11.99	$-12.54	$-8.74	$-8.00	$-7.87	$-7.48	$-8.42	$-6.09	$-3.87	$-3.87
OCF/Share	$-105.96	$-109.92	$-97.57	$-88.36	$-11.21	$-9.57	$-9.89	$-10.28	$-10.00	$-10.74	$-11.01	$-9.81	$-9.94	$-6.73	$-6.67	$-7.16	$-7.28	$-8.36	$-6.05	$-3.86	$-3.86
Cash/Share	$214.92	$188.90	$168.57	$158.70	$19.00	$10.34	$14.55	$10.84	$8.06	$20.73	$17.31	$17.52	$14.73	$14.14	$12.25	$10.26	$9.95	$8.00	$9.83	$6.53	$6.53
EBITDA/Share	$-101.24	$-115.72	$-118.43	$-112.43	$-13.89	$-12.65	$-11.95	$-12.47	$-12.04	$-9.85	$-10.09	$-9.75	$-9.94	$-9.90	$-9.74	$-10.01	$-9.42	$-8.72	$-6.74	$-4.08	$-4.08
Debt/Share	$66.75	$65.90	$64.90	$63.88	$8.46	$30.90	$0.45	$5.21	$5.46	$4.14	$4.48	$4.28	$4.49	$5.02	$4.81	$4.75	$4.76	$4.63	$3.70	$2.40	$2.40
Net Debt/Share	$-148.17	$-123.00	$-103.67	$-94.82	$-10.54	$20.57	$-14.11	$-5.63	$-2.60	$-16.58	$-12.83	$-13.24	$-10.23	$-9.12	$-7.43	$-5.51	$-5.20	$-3.37	$-6.13	$-4.13	$-4.13

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2.001
Altman Z-Prime	snapshot only																				-3.104
Piotroski F-Score	2	2	1	1	1	1	3	3	2	3	2	3	3	2	2	2	2	2	1	2	2
Beneish M-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-4.43	—	—	—
Ohlson O-Score	snapshot only																				-3.796
ROIC (Greenblatt)	snapshot only																				-60.53%
Net-Net WC	snapshot only																				$3.43
EVA	snapshot only																				$-62816440.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BB
Credit Score	38.12	29.30	30.34	30.78	40.42	20.00	64.75	31.71	30.23	54.86	75.32	59.61	48.32	48.15	42.71	42.92	48.35	40.70	42.99	42.63	42.632
Credit Grade	snapshot only																				12
Credit Trend	snapshot only																				-0.287
Implied Spread (bps)	snapshot only																				475.000
Industry Credit Rank	snapshot only																				38
Sector Credit Rank	snapshot only																				34

KRRO NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet